For the Inventor, By the Inventor

Enter assignee name

Athlone, Ireland

Elan Corporation, Plc

USPTO Granted Patents = 67

% Expired Patents = 1.5

CIPO Patents = 2

Trademarks = 2

Forward Citations = 9,177

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Donald E Panoz (20 out of 22 patents)

Edward J Geoghegan (15 out of 20 patents)

Joseph Gross (12 out of 77 patents)

4. Seamus Mulligan (12 out of 15 patents)

5. Izrail Tsals (7 out of 35 patents)

6. Daniel Joseph O'Mahony (7 out of 17 patents)

7. Randall T Sparks (6 out of 7 patents)

8. Gilad Lavi (5 out of 45 patents)

9. Paul Stark (5 out of 10 patents)

10. Niall M M Fanning (4 out of 4 patents)

11. John G Devane (4 out of 15 patents)

12. Kenneth Iain Cumming (3 out of 9 patents)

13. Haim Danon (3 out of 4 patents)

14. Owen I Corrigan (3 out of 6 patents)

15. Gilbert Corneille (3 out of 3 patents)

Core Competencies:

Drug Delivery

Controlled Release

Multiparticulate

Peptides

Syringe

Absorption

Pharmaceutical

Formulations

Transport

Composition

Injection

Device

67 patents: Sort by Forward Citations

1. 7468365 - Lactam compound (2008-12-23),

2. 7135457 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-11-14),

3. 6902742 - Multiparticulate modified release composition (2005-06-07),

4. 6830560 - Automatic syringe (2004-12-14),

5. 6793936 - Multiparticulate modified release composition (2004-09-21),

6. 6780846 - Membrane translocating peptide drug delivery system (2004-08-24),

7. 6730325 - Multiparticulate modified release composition (2004-05-04),

8. 6699973 - Antibodies to peptides that target GIT receptors and related methods (2004-03-02),

9. 6521737 - Peptides which enhance transport across tissues and methods of identifying and using the same (2003-02-18),

10. 6423334 - Composition and method for enhancing transport across gastrointestinal tract cell layers (2002-07-23),

11. 6399100 - Controlled release pharmaceutical compositions containing tiagabine (2002-06-04),

12. D455207 - Drug conversion device (2002-04-03),

13. 6361938 - Peptides which enhance transport across tissues and methods of identifying and using the same (2002-03-26),

14. 6346613 - Composition and method for enhancing paracellular transport across cell layers (2002-02-12),

15. 6346095 - Needle and method for delivery of fluids (2002-02-12),

Company Overview

Elan Corporation, Plc, headquartered in Athlone, Ireland, specializes in innovative drug delivery systems that enhance the efficacy and safety of pharmaceutical products. The company focuses on core technologies such as controlled release mechanisms, multiparticulate formulations, and peptide delivery systems. Elan's expertise in absorption and syringe-based delivery methods positions it as a leader in the pharmaceutical industry, dedicated to advancing therapeutic solutions that meet diverse patient needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

67 Patents

#2 in Athlone

#45 in Ireland

#11,040 in the World

Athlone, Ireland

Elan Corporation, Plc

Forward Citations = 9,177

56 inventors:

Donald E Panoz (20 out of 22 patents)

Edward J Geoghegan (15 out of 20 patents)

Joseph Gross (12 out of 77 patents)

4. Seamus Mulligan (12 out of 15 patents)

5. Izrail Tsals (7 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elan Corporation, Plc. Retrieved from https://idiyas.com/company/elan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…